Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Aktionariat AG

History from 3 Jun 2020

UID
CHE-453.438.437
Legal form
AG
Canton
ZH
Founded
3 Jun 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 180k
45k90k135k180k17 Aug 2021 · CHF 120k2 May 2022 · CHF 133k17 May 2023 · CHF 150k30 May 2024 · CHF 165k24 Dec 2025 · CHF 180k20222023202420252026
  • shares

Record

  1. Company formed

    Founded 3 Jun 2020

    SHAB HR01-1004904392 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 120’000
    Shares
    1’000’000 → 1’200’000
    New shares, % of post-step shares
    16.7% (200’000 new)

    Aktienkapital neu: CHF 120'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 120'000.00 [bisher: CHF 100'000.00]. Aktien neu: 1'200'000 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005271958 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    120’000 → 133’000
    Shares
    1’200’000 → 1’330’000
    New shares, % of post-step shares
    9.8% (130’000 new)

    Aktienkapital neu: CHF 133'000.00 [bisher: CHF 120'000.00]. Liberierung Aktienkapital neu: CHF 133'000.00 [bisher: CHF 120'000.00]. Aktien neu: 1'330'000 Namenaktien zu CHF 0.10 [bisher: 1'200'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005462136 ↗
  4. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    133’000 → 150’000
    Shares
    1’330’000 → 1’500’000
    New shares, % of post-step shares
    11.3% (170’000 new)

    Aktienkapital neu: CHF 150'000.00 [bisher: CHF 133'000.00]. Liberierung Aktienkapital neu: CHF 150'000.00 [bisher: CHF 133'000.00]. Aktien neu: 1'500'000 Namenaktien zu CHF 0.10 [bisher: 1'330'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005747958 ↗
  5. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    150’000 → 165’000
    Shares
    1’500’000 → 1’650’000
    New shares, % of post-step shares
    9.1% (150’000 new)

    Aktienkapital neu: CHF 165'000.00 [bisher: CHF 150'000.00]. Liberierung Aktienkapital neu: CHF 165'000.00 [bisher: CHF 150'000.00]. Aktien neu: 1'650'000 Namenaktien zu CHF 0.10 [bisher: 1'500'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006043256 ↗
  6. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    165’000 → 180’000
    Shares
    1’650’000 → 1’800’000
    New shares, % of post-step shares
    8.3% (150’000 new)

    Aktienkapital neu: CHF 180'000.00 [bisher: CHF 165'000.00]. Liberierung Aktienkapital neu: CHF 180'000.00 [bisher: CHF 165'000.00]. Aktien neu: 1'800'000 Namenaktien zu CHF 0.10 [bisher: 1'650'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.62 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006523484 ↗

Published by 8 Oct 2026